Highlights and Quick Summary
Current P/B ratio of Benitec Biopharma Limited is 3.29 (as of June 30, 2022)
- P/B ratio for the quarter ending December 31, 2022 was 0.55 (a -83.23% decrease compared to previous quarter)
- Year-over-year quarterly P/B ratio decreased by -72.08%
- Annual P/B ratio for 2022 was 3.29 (a 59.18% increase from previous year)
- Annual P/B ratio for 2022 was 2.07 (a 126.53% increase from previous year)
- Annual P/B ratio for 2021 was 0.91 (a -7.11% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical P/B ratio of Benitec Biopharma Limited
Most recent P/B ratioof BNTC including historical data for past 10 years.Interactive Chart of P/B ratio of Benitec Biopharma Limited
Benitec Biopharma Limited P/B ratio for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | 0.55 | 3.29 | 2.54 | 3.29 |
2021 | – | 1.98 | 0.91 | 2.25 | 0.91 |
2020 | 0.88 | 0.9 | 0.0 | 0.0 | 0.0 |
2019 | – | – | 0.44 | 0.62 | 0.44 |
2018 | – | – | – | – | 1.22 |
2017 | – | – | – | 1.28 | 0.91 |
2016 | – | – | – | 0.69 | 0.0 |
2015 | – | – | – | – | 0.0 |
2014 | – | – | – | – | 0.0 |
2013 | – | – | – | – | 0.0 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology